Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinib

Richard D. Press, Stephanie G. Willis, Jennifer Laudadio, Michael J. Mauro, Michael W.N. Deininger

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Fingerprint

Dive into the research topics of 'Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinib'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds